Contraception
Audio Summaries

Postpartum Contraceptive Use Among Medicaid Beneficiaries Following Idaho's Abortion Ban

Aug 6, 2026

This study investigates the impact of Idaho's abortion ban on postpartum contraceptive use among Medicaid beneficiaries. The authors found that the ban was associated with significant decreases in the use of the most effective contraception within 90 days postpartum and lower attendance at postpartum visits, highlighting potential unintended consequences of abortion restrictions on reproductive health care access.

Prenatal Incarceration Exposure and Postpartum Contraceptive Use: Findings from the Pregnancy Risk Assessment Monitoring System

Aug 3, 2026

The study aimed to determine the association between prenatal incarceration exposure and postpartum contraceptive use among new mothers. Analyzing data from over 111,000 respondents, the authors found that those with incarceration exposure had significantly lower odds of using any postpartum contraception and were less likely to use condoms, while showing higher odds of abstinence. The results highlight the need for integrated support systems to enhance contraceptive access for individuals impacted by incarceration.

Comparing the TCu380A and a small Nova-T copper IUD: secondary analysis of discontinuation probabilities, bleeding outcomes and satisfaction in nulliparous participants from a 3-year randomized trial

Jul 31, 2026

The authors aimed to compare the discontinuation rates, satisfaction, and bleeding outcomes between two copper IUDs, the NTCu380-Mini and TCu380A, in a nulliparous population over three years. Results indicated that NTCu380-Mini users experienced lower rates of discontinuation due to bleeding and pain, as well as higher satisfaction compared to TCu380A users. These findings suggest that the NTCu380-Mini may offer significant advantages for nulliparous individuals seeking non-hormonal contraception.

Fetal demise duration and bleeding outcomes at the time of dilation and evacuation

Jul 30, 2026

The authors aimed to investigate the relationship between the duration of intrauterine fetal demise (IUFD) and the risk of bleeding complications during dilation and evacuation (D&E) procedures. Their findings indicated that while the overall rates of disseminated intravascular coagulopathy (DIC) and hemorrhage were low and not significantly associated with IUFD duration, patients with IUFD lasting more than 28 days had higher odds of these complications compared to those with shorter durations. The study underscores the relative safety of D&E for second trimester IUFDs, particularly within the first four weeks post-diagnosis.

Tubal Permanent Contraception on TikTok: Content Themes and Quality of Educational Videos

Jul 29, 2026

This study aims to analyze the content and quality of TikTok videos related to tubal permanent contraception, focusing on differences between videos created by healthcare providers and non-professionals. The findings reveal that healthcare providers produced higher quality and more understandable educational content, with key themes including pregnancy after permanent contraception and access to these procedures. This underscores the critical role of healthcare professionals in disseminating accurate health information on social media platforms.

Society of Family Planning Research Practice Support: Key considerations for contraceptive misinformation research

Jul 29, 2026

The authors aim to provide guidance for researchers studying contraceptive misinformation, highlighting its impact on health outcomes and decision-making in reproductive health. They define key terms related to the information ecosystem and offer actionable recommendations for each stage of the research process, including study design, ethical considerations, and dissemination strategies. This framework is intended to enhance the quality and impact of research in the field of contraceptive misinformation.

Contraceptive practices during monitoring for molar pregnancy: A mixed methods analysis

Jul 14, 2026

The authors aimed to investigate contraceptive practices and the factors influencing contraceptive decision-making during the post-molar beta-hCG monitoring period. Their mixed methods analysis revealed that over 21% of patients did not use contraception during this time, with significant variations in contraceptive methods based on demographic factors. Qualitative interviews highlighted key themes in decision-making, including the importance of monitoring and the desire for a quick return to fertility, indicating a need for enhanced contraceptive counseling in this population.

Findings from the Choices about Abortion CaRE Options (CARE) Study: A Discrete-Choice Experiment

Jul 6, 2026

The study aimed to quantify how individuals considering an abortion at eight weeks gestation make trade-offs among various attributes of abortion care options, such as wait time, travel distance, and costs. Through a discrete-choice experiment involving 500 respondents, the authors identified three distinct preference patterns, highlighting that while some prioritize cost, others value expediency and privacy. The findings suggest that understanding these diverse preferences can aid in providing more patient-centered abortion care, particularly in light of current challenges to abortion access.

Crisis Pregnancy Center Names in the United States, 2024

Jul 6, 2026

The authors aimed to analyze the naming conventions of 2,633 crisis pregnancy centers (CPCs) in the United States in 2024, categorizing them based on whether they portrayed themselves as healthcare facilities or were unbiased and supportive of reproductive autonomy. They found that a significant portion of CPC names may misrepresent their true nature, with 16.0% presenting as healthcare facilities and 12.6% being unbiased. Notably, the study revealed no association between the naming patterns and state policies regarding CPC funding and abortion bans.

Comparative effectiveness of 200mcg versus 400mcg misoprostol dosing for medication abortion from 24-27 weeks' gestation

Jul 4, 2026

The authors aimed to compare the effectiveness and adverse outcomes of two dosing regimens of misoprostol (200mcg vs. 400mcg) for medication abortion between 24-27 weeks' gestation. Their retrospective cohort study found that while both dosing regimens resulted in similar overall outcomes, the 200mcg group showed a trend towards longer time to placental expulsion and higher rates of complications, suggesting the need for larger studies to determine the optimal dosing.